Monthly
US$200
Billed every month
Sign in to subscribeAs of 16 November 2026, for Bisoprolol Fumarate and Amlodipine Besylate Tablets, 9 applications are listed as under review at China's CDE; 2 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 36 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 1 applicationAccepted: 3 applicationsNo longer listed under review: 1 applicationSupplement delivery: 1 application
Current coverage may be incomplete
Free: up to 3 drugs, Monday digest. Sign in with Google or an email code. No card needed.
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Loaded records: 36 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 36 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Hainan Guang Sheng Yu Pharmaceutical Co., Ltd. romanized | Hua Yi Tai Kang Pharma Co., Ltd. romanized | 国药准字H20266033 | 2026/09/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Hua Su Pharmaceutical Co., Ltd. romanized | Shandong Hua Su Pharmaceutical Co., Ltd. romanized | 国药准字H20265927 | 2026/09/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20265552 | 2026/08/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Yi Kang Pharma Co., Ltd. romanized | Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20265371 | 2026/07/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20265149 | 2026/07/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanghai Heng Shan Pharma Co., Ltd. romanized | Shanghai Heng Shan Pharma Co., Ltd. romanized | 国药准字H20264939 | 2026/06/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20264871 | 2026/06/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | 国药准字H20264395 | 2026/05/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jinan Liang Fu Jing He Pharmaceuticals Technology Co., Ltd. romanized | Yan Tai Lu Yin Pharma Co., Ltd. romanized | 国药准字H20264189 | 2026/04/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20264014 | 2026/04/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20263790 | 2026/03/31 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Fang Sheng Jian Meng Pharma Co., Ltd. romanized | Hunan Fang Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20263439 | 2026/02/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | 2026/02/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Jin Cheng Tai Er Pharmaceutical Co., Ltd. romanized | Beijing Jin Cheng Tai Er Pharmaceutical Co., Ltd. romanized | 国药准字H20263409 | 2026/02/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | 国药准字H20256486 | 2026/01/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20263116 | 2026/01/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Long Hai Pharma Co., Ltd. romanized | Hebei Long Hai Pharma Co., Ltd. romanized | 国药准字H20263131 | 2026/01/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Cheng Kang Pharma Co., Ltd. romanized | Jiangsu Cheng Kang Pharma Co., Ltd. romanized | 国药准字H20263043 | 2026/01/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20263046 | 2026/01/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20256468 | 2025/12/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei Guo Gao Pharma Co., Ltd. romanized | Huayi Pharmaceuticals (Anhui) Co., Ltd. | 国药准字H20256298 | 2025/12/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20256327 | 2025/12/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Huayi Pharmaceuticals (Anhui) Co., Ltd. | Huayi Pharmaceuticals (Anhui) Co., Ltd. | 国药准字H20256108 | 2025/12/03 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hua Run Sai Ke Pharma Co., Ltd. romanized | Hua Run Sai Ke Pharma Co., Ltd. romanized | 国药准字H20255995 | 2025/11/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Giantech Hi-technology Development Co., Ltd. | Chengdu Tian Tai Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20255317 | 2025/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Hua Yuan Pharma Co., Ltd. romanized | Zhejiang Hua Yuan Pharma Co., Ltd. romanized | 国药准字H20255101 | 2025/08/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20254602 | 2025/06/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Tian Da Pharma (Zhuhai) Co., Ltd. romanized | Tian Da Pharma (Zhuhai) Co., Ltd. romanized | 国药准字H20254574 | 2025/06/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | 国药准字H20254303 | 2025/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | Huayi Pharmaceuticals (Anhui) Co., Ltd. | 国药准字H20254304 | 2025/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Qidu Pharmaceutical Co., Ltd. | Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20254358 | 2025/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20249788 | 2024/12/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | Guangdong An Nuo Pharma Co., Ltd. romanized | 国药准字H20249542 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangxi Shimei Pharmaceutical Co., Ltd | Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20249161 | 2024/10/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243824 | 2024/05/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Shuo De Pharma Co., Ltd. romanized | Chengdu Shuo De Pharma Co., Ltd. romanized | 国药准字H20243459 | 2024/04/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
Loaded records: 36 distinct approval numbers and 36 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Beijing Jin Cheng Tai Er Pharmaceutical Co., Ltd. romanized | 国药准字H20263409 | See source | Category B | XC07FBB249A001010100085 | NHSA |
| Hua Run Sai Ke Pharma Co., Ltd. romanized | 国药准字H20255995 | See source | Category B | XC07FBB249A001010100111 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20254602 | See source | Category B | XC07FBB249A001010100177 | NHSA |
| Tian Da Pharma (Zhuhai) Co., Ltd. romanized | 国药准字H20254574 | See source | Category B | XC07FBB249A001010100560 | NHSA |
| Shanghai Heng Shan Pharma Co., Ltd. romanized | 国药准字H20264939 | See source | Category B | XC07FBB249A001010100676 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20263116 | See source | Category B | XC07FBB249A001010101503 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20263046 | See source | Category B | XC07FBB249A001010102013 | NHSA |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20264014 | See source | Category B | XC07FBB249A001010102353 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243824 | See source | Category B | XC07FBB249A001010102763 | NHSA |
| Hebei Wan Long Pharma Co., Ltd. romanized | 国药准字H20263131 | See source | Category B | XC07FBB249A001010102766 | NHSA |
| Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | 国药准字H20256486 | See source | Category B | XC07FBB249A001010103006 | NHSA |
| Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20265552 | See source | Category B | XC07FBB249A001010103205 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20254358 | See source | Category B | XC07FBB249A001010104145 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20256468 | See source | Category B | XC07FBB249A001010104188 | NHSA |
| Zhejiang Hua Yuan Pharma Co., Ltd. romanized | 国药准字H20255101 | See source | Category B | XC07FBB249A001010104646 | NHSA |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20249161 | See source | Category B | XC07FBB249A001010105356 | NHSA |
| Ningxia Kang Ya Pharma Co., Ltd. romanized | 国药准字H20265055 | See source | Category B | XC07FBB249A001010105911 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | See source | Category B | XC07FBB249A001010106632 | NHSA |
| Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20264871 | See source | Category B | XC07FBB249A001010110323 | NHSA |
| Hainan Guang Sheng Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20266033 | See source | Category B | XC07FBB249A001010181251 | NHSA |
| Jiangsu Cheng Kang Pharma Co., Ltd. romanized | 国药准字H20263043 | See source | Category B | XC07FBB249A001010182219 | NHSA |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H20249542 | See source | Category B | XC07FBB249A001010183014 | NHSA |
| Chengdu Giantech Hi-technology Development Co., Ltd. | 国药准字H20255317 | See source | Category B | XC07FBB249A001010183325 | NHSA |
| Yan Tai Lu Yin Pharma Co., Ltd. romanized | 国药准字H20264189 | See source | Category B | XC07FBB249A001010183358 | NHSA |
| Merck Kft. | 国药准字HJ20210030 | See source | Category B | XC07FBB249A001010183599 | NHSA |
| Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized | 国药准字H20249788 | See source | Category B | XC07FBB249A001010183668 | NHSA |
| Chengdu Shuo De Pharma Co., Ltd. romanized | 国药准字H20243459 | See source | Category B | XC07FBB249A001010183830 | NHSA |
| Hefei Guo Gao Pharma Co., Ltd. romanized | 国药准字H20256298 | See source | Category B | XC07FBB249A001010183883 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254304 | See source | Category B | XC07FBB249A001010184135 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20264208 | See source | Category B | XC07FBB249A001010184206 | NHSA |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264395 | See source | Category B | XC07FBB249A001010184211 | NHSA |
| Hua Yi Pharma Technology (Anhui) Co., Ltd. romanized | 国药准字H20256108 | See source | Category B | XC07FBB249A001010184212 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254303 | See source | Category B | XC07FBB249A001010184221 | NHSA |
| Name not romanized | 国药准字H20256327 | See source | Category B | XC07FBB249A001010184294 | NHSA |
| Guangdong Fang Sheng Jian Meng Pharma Co., Ltd. romanized | 国药准字H20263439 | See source | Category B | XC07FBB249A001010184434 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20263790 | See source | Category B | XC07FBB249A001010185453 | NHSA |
| Beijing Jin Cheng Tai Er Pharmaceutical Co., Ltd. romanized | 国药准字H20263409 | See source | Category B | XC07FBB249A001010200085 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20254602 | See source | Category B | XC07FBB249A001010200177 | NHSA |
| Tian Da Pharma (Zhuhai) Co., Ltd. romanized | 国药准字H20254574 | See source | Category B | XC07FBB249A001010200560 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20263116 | See source | Category B | XC07FBB249A001010201503 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20263046 | See source | Category B | XC07FBB249A001010202013 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243824 | See source | Category B | XC07FBB249A001010202763 | NHSA |
| Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | 国药准字H20256486 | See source | Category B | XC07FBB249A001010203006 | NHSA |
| Guo Yao Group Rong Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20265552 | See source | Category B | XC07FBB249A001010203205 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20254358 | See source | Category B | XC07FBB249A001010204145 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20256468 | See source | Category B | XC07FBB249A001010204188 | NHSA |
| Zhejiang Hua Yuan Pharma Co., Ltd. romanized | 国药准字H20255101 | See source | Category B | XC07FBB249A001010204646 | NHSA |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20249161 | See source | Category B | XC07FBB249A001010205356 | NHSA |
| Ningxia Kang Ya Pharma Co., Ltd. romanized | 国药准字H20265055 | See source | Category B | XC07FBB249A001010205911 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | See source | Category B | XC07FBB249A001010206632 | NHSA |
| Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20264871 | See source | Category B | XC07FBB249A001010210323 | NHSA |
| Jiangsu Cheng Kang Pharma Co., Ltd. romanized | 国药准字H20263043 | See source | Category B | XC07FBB249A001010282219 | NHSA |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H20249542 | See source | Category B | XC07FBB249A001010283014 | NHSA |
| Yan Tai Lu Yin Pharma Co., Ltd. romanized | 国药准字H20264189 | See source | Category B | XC07FBB249A001010283358 | NHSA |
| Merck Kft. | 国药准字HJ20210030 | See source | Category B | XC07FBB249A001010283599 | NHSA |
| Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized | 国药准字H20249788 | See source | Category B | XC07FBB249A001010283668 | NHSA |
| Chengdu Shuo De Pharma Co., Ltd. romanized | 国药准字H20243459 | See source | Category B | XC07FBB249A001010283830 | NHSA |
| Hefei Guo Gao Pharma Co., Ltd. romanized | 国药准字H20256298 | See source | Category B | XC07FBB249A001010283883 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254304 | See source | Category B | XC07FBB249A001010284135 | NHSA |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264395 | See source | Category B | XC07FBB249A001010284211 | NHSA |
| Hua Yi Pharma Technology (Anhui) Co., Ltd. romanized | 国药准字H20256108 | See source | Category B | XC07FBB249A001010284212 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254303 | See source | Category B | XC07FBB249A001010284221 | NHSA |
| Name not romanized | 国药准字H20256327 | See source | Category B | XC07FBB249A001010284294 | NHSA |
| Guangdong Fang Sheng Jian Meng Pharma Co., Ltd. romanized | 国药准字H20263439 | See source | Category B | XC07FBB249A001010284434 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20263790 | See source | Category B | XC07FBB249A001010285453 | NHSA |
| Beijing Jin Cheng Tai Er Pharmaceutical Co., Ltd. romanized | 国药准字H20263409 | See source | Category B | XC07FBB249A001010300085 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20254602 | See source | Category B | XC07FBB249A001010300177 | NHSA |
| Tian Da Pharma (Zhuhai) Co., Ltd. romanized | 国药准字H20254574 | See source | Category B | XC07FBB249A001010300560 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20263116 | See source | Category B | XC07FBB249A001010301503 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20263046 | See source | Category B | XC07FBB249A001010302013 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243824 | See source | Category B | XC07FBB249A001010302763 | NHSA |
| Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | 国药准字H20256486 | See source | Category B | XC07FBB249A001010303006 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20254358 | See source | Category B | XC07FBB249A001010304145 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20256468 | See source | Category B | XC07FBB249A001010304188 | NHSA |
| Zhejiang Hua Yuan Pharma Co., Ltd. romanized | 国药准字H20255101 | See source | Category B | XC07FBB249A001010304646 | NHSA |
| Ningxia Kang Ya Pharma Co., Ltd. romanized | 国药准字H20265055 | See source | Category B | XC07FBB249A001010305911 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | See source | Category B | XC07FBB249A001010306632 | NHSA |
| Jiangsu Cheng Kang Pharma Co., Ltd. romanized | 国药准字H20263043 | See source | Category B | XC07FBB249A001010382219 | NHSA |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H20249542 | See source | Category B | XC07FBB249A001010383014 | NHSA |
| Yan Tai Lu Yin Pharma Co., Ltd. romanized | 国药准字H20264189 | See source | Category B | XC07FBB249A001010383358 | NHSA |
| Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized | 国药准字H20249788 | See source | Category B | XC07FBB249A001010383668 | NHSA |
| Chengdu Shuo De Pharma Co., Ltd. romanized | 国药准字H20243459 | See source | Category B | XC07FBB249A001010383830 | NHSA |
| Hefei Guo Gao Pharma Co., Ltd. romanized | 国药准字H20256298 | See source | Category B | XC07FBB249A001010383883 | NHSA |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264395 | See source | Category B | XC07FBB249A001010384211 | NHSA |
| Hua Yi Pharma Technology (Anhui) Co., Ltd. romanized | 国药准字H20256108 | See source | Category B | XC07FBB249A001010384212 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254303 | See source | Category B | XC07FBB249A001010384221 | NHSA |
| Name not romanized | 国药准字H20256327 | See source | Category B | XC07FBB249A001010384294 | NHSA |
| Guangdong Fang Sheng Jian Meng Pharma Co., Ltd. romanized | 国药准字H20263439 | See source | Category B | XC07FBB249A001010384434 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20263790 | See source | Category B | XC07FBB249A001010385453 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20254602 | See source | Category B | XC07FBB249A001010400177 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20243824 | See source | Category B | XC07FBB249A001010402763 | NHSA |
| Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | 国药准字H20256486 | See source | Category B | XC07FBB249A001010403006 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20254358 | See source | Category B | XC07FBB249A001010404145 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20256468 | See source | Category B | XC07FBB249A001010404188 | NHSA |
| Ningxia Kang Ya Pharma Co., Ltd. romanized | 国药准字H20265055 | See source | Category B | XC07FBB249A001010405911 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | See source | Category B | XC07FBB249A001010406632 | NHSA |
| Jiangsu Cheng Kang Pharma Co., Ltd. romanized | 国药准字H20263043 | See source | Category B | XC07FBB249A001010482219 | NHSA |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H20249542 | See source | Category B | XC07FBB249A001010483014 | NHSA |
| Anhui Bo Nuo Mei Ke Biopharmaceuticals Co., Ltd. romanized | 国药准字H20249788 | See source | Category B | XC07FBB249A001010483668 | NHSA |
| Zhejiang Bai Dai Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264395 | See source | Category B | XC07FBB249A001010484211 | NHSA |
| Hua Yi Pharma Technology (Anhui) Co., Ltd. romanized | 国药准字H20256108 | See source | Category B | XC07FBB249A001010484212 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254303 | See source | Category B | XC07FBB249A001010484221 | NHSA |
| Name not romanized | 国药准字H20256327 | See source | Category B | XC07FBB249A001010484294 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20263790 | See source | Category B | XC07FBB249A001010485453 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20254602 | See source | Category B | XC07FBB249A001010500177 | NHSA |
| Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | 国药准字H20256486 | See source | Category B | XC07FBB249A001010503006 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20254358 | See source | Category B | XC07FBB249A001010504145 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20256468 | See source | Category B | XC07FBB249A001010504188 | NHSA |
| Ningxia Kang Ya Pharma Co., Ltd. romanized | 国药准字H20265055 | See source | Category B | XC07FBB249A001010505911 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | See source | Category B | XC07FBB249A001010506632 | NHSA |
| Hua Yi Pharma Technology (Anhui) Co., Ltd. romanized | 国药准字H20256108 | See source | Category B | XC07FBB249A001010584212 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254303 | See source | Category B | XC07FBB249A001010584221 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20263790 | See source | Category B | XC07FBB249A001010585453 | NHSA |
| Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | 国药准字H20256486 | See source | Category B | XC07FBB249A001010603006 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20256468 | See source | Category B | XC07FBB249A001010604188 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | See source | Category B | XC07FBB249A001010606632 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20263790 | See source | Category B | XC07FBB249A001010685453 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | See source | Category B | XC07FBB249A001010706632 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | See source | Category B | XC07FBB249A001010806632 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | See source | Category B | XC07FBB249A001010906632 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20263479 | See source | Category B | XC07FBB249A001011006632 | NHSA |
| Hebei Wan Long Pharma Co., Ltd. romanized | 国药准字H20263131 | See source | Category B | XC07FBB249A001020102766 | NHSA |
| Chengdu Giantech Hi-technology Development Co., Ltd. | 国药准字H20255317 | See source | Category B | XC07FBB249A001020183325 | NHSA |
| Chengdu Giantech Hi-technology Development Co., Ltd. | 国药准字H20255317 | See source | Category B | XC07FBB249A001020283325 | NHSA |
| Chengdu Giantech Hi-technology Development Co., Ltd. | 国药准字H20255317 | See source | Category B | XC07FBB249A001020383325 | NHSA |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20264014 | See source | Category B | XC07FBB249A001020102353 | NHSA |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20264014 | See source | Category B | XC07FBB249A001020202353 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Loaded records: 9 filings and 9 distinct first applicants.
Generic 9
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Shandong Si Bang De Pharmaceutical Co., Ltd. romanized; Shandong Nuo He Kang Pharma Co., Ltd. romanized | CYHS2602466 | Generic | 2026/10/09 | Not stated by source | CDE |
| Hong Yue Technology (Hu Zhou) Co., Ltd. romanized; Ningbo Da Hong Ying Pharma Co., Ltd. romanized | CYHS2504445 | Generic | 2025/12/27 | Not stated by source | CDE |
| Xin Shi Yang Guang Pharma (Hebei) Co., Ltd. romanized | CYHS2504183 | Generic | 2025/12/05 | Not stated by source | CDE |
| Shenzhen Shi Yu Jian Biopharmaceuticals Co., Ltd. romanized; Shenzhen Shi Xin Yang Wei Kang Technology Co., Ltd. romanized | CYHS2503834 | Generic | 2025/10/30 | Not stated by source | CDE |
| Shanxi Tong Da Pharma Co., Ltd. romanized | CYHS2503085 | Generic | 2025/08/22 | Not stated by source | CDE |
| Xin Xiang Shuang Lu Pharma Co., Ltd. romanized | CYHS2502784 | Generic | 2025/08/02 | Not stated by source | CDE |
| Guangdong Da Peng Pharma Co., Ltd. romanized; Yu Song Yuan Pharma Co., Ltd. romanized | CYHS2502402 | Generic | 2025/07/08 | Not stated by source | CDE |
| Hunan Hui Ze Biopharmaceuticals Technology Co., Ltd. romanized; Hunan Jiudian Pharmaceutical Co., Ltd | CYHS2303182 | Generic | 2023/11/21 | Not stated by source | CDE |
| Suzhou Hong Sen Pharma Co., Ltd. romanized | CYHS2602763 | Generic | 2026/11/10 | Not stated by source | CDE |
Loaded records: 3 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Shandong Si Bang De Pharmaceutical Co., Ltd. romanized; Shandong Nuo He Kang Pharma Co., Ltd. romanized | CYHS2602466 | Generic | 2026/10/09 | Not stated by source | CDE |
| Shandong Si Bang De Pharmaceutical Co., Ltd. romanized; Shandong Nuo He Kang Pharma Co., Ltd. romanized | CYHS2600578 | Generic | 2026/02/28 | Not stated by source | CDE |
| Suzhou Hong Sen Pharma Co., Ltd. romanized | CYHS2602763 | Generic | 2026/11/10 | Not stated by source | CDE |
Non-component matches: 0 companies with A status and 0 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/16 06:35. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
CYHS2501799 · 国药准字H20266541
Fact date: 2026/11/10 · Publication date: 2026/11/13 · Site observation date: 2026/11/14
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 71 ↗CYHS2602763
Fact date: 2026/11/10 · Site observation date: 2026/11/11
View source ↗CYHS2501799
Fact date: 2026/10/24 · Site observation date: 2026/10/24
Accepted: 2025/05/17
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/13 (approval no.: 国药准字H20266541; approval date: 2026/11/10) · NMPA source · row 71
NMPA · Table row 71 ↗ View source ↗CYHB2601754
Fact date: 2026/10/16 · Publication date: 2026/10/19 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 10 ↗CYHS2602466
Fact date: 2026/10/09 · Site observation date: 2026/10/22
View source ↗CYHB2601754
Fact date: 2026/09/17 · Site observation date: 2026/10/21
View source ↗Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
First index-page publication dates: 2026-10-29 to 2026-11-13; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 11/30; discovered pending details: 9. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
US$200
Billed every month
Sign in to subscribeUS$540
Billed every three months
US$180 per month
Sign in to subscribeUS$1,920
Billed every year
US$160 per month
Sign in to subscribeSeparate one-time purchase
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy
No account needed.
Covers all drugs in the loaded CDE records, not only this one: weekly acceptance counts, top-10 lists and definitions. View the latest report